Quick medicine delivery startup Plazza has raised $15 Mn (about ₹145 Cr) in a Series A funding round co-led by Accel, Elevation Capital and Nexus Venture Partners.
The round also saw participation from existing investors All In Capital and Better Capital.
The Bengaluru-based startup plans to use the fresh capital to strengthen its technology platform and deepen its AI-led inventory and assortment capabilities. A portion of the funding will go towards building operational infrastructure and expanding its pharmacy network.
Founded in 2024 by former Zomato executive Aman Priyadarshi, Plazza operates technology-enabled neighbourhood pharmacies that deliver medicines within 15 to 30 minutes.
The startup currently operates two stores in Bengaluru and plans to expand across more neighbourhoods in the city before entering new markets.
Plazza said its stores stock more than 40,000 pharmaceutical SKUs, compared with roughly 5,000 medicines typically available at neighbourhood pharmacies. It claims this enables prescription fill rates of more than 95% as against an industry average of about 50% to 60%.
The startup uses an AI-powered inventory system to determine which medicines should be stocked at each store based on neighbourhood-level demand and local prescription patterns. According to Plazza, only about half of the top-selling medicines overlap across its two Bengaluru stores, reflecting significant differences in prescription demand across micro-markets.
Unlike traditional pharmacies that primarily optimise inventory for walk-in customers or e-pharmacies that offer wider selections with longer delivery timelines, Plazza aims to combine broader medicine availability with rapid local fulfilment.
“This investment allows us to strengthen the intelligence behind every Plazza store, expand into new neighbourhoods, and build a pharmacy experience that customers can consistently rely on,” founder and CEO Priyadarshi said.
Prior to this funding, Plazza raised $1.4 Mn from All In Capital and Better Capital in 2025.
Plazza said its gross merchandise value increased nearly 27-fold between June 2025 and March 2026. It added that repeat customers now spend about 30% more per order than first-time users.
Plazza competes with platforms such as Tata 1mg, PharmEasy, Netmeds, Apollo Pharmacy, Pillo and Practo.
The funding comes as quick commerce players continue expanding beyond grocery delivery into categories such as electronics, beauty, food and healthcare. However, medicine delivery remains more complex due to prescription requirements, stricter supply chain norms and regulatory oversight.
The broader quick commerce market in India is projected to grow to $68 Bn in GMV by 2031 from $8.3 Bn in 2026, expanding at a CAGR of 52%. While medicines remain a relatively small segment within that market, startups such as Plazza are betting that faster fulfilment and improved inventory availability can help capture a larger share of healthcare spending.
The post Plazza Bags $15 Mn To Expand Quick Medicine Delivery Business appeared first on Inc42 Media.
https://ift.tt/rhSN1Ly
0 Comments